Skip to content

Surveillance study of the frequency of the primary aldosteronism included in the hypertensive patient for an untreated hypertensive patient at the time of the first medical examination: multi-center survey.

Surveillance study of the frequency of the primary aldosteronism included in the hypertensive patient for an untreated hypertensive patient at the time of the first medical examination: multi-center survey. - The survey of primary aldosteronism.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009328
Enrollment
5000
Registered
2012-11-13
Start date
2012-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

None listed

Sponsors

Japan Physicians Association
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The hypertensive patient who is not treated at the time of the first medical examination. The patient who has not taken the hypotensive drug one month or more.

Exclusion criteria

Exclusion criteria: The patient who is taking a hypotensive drug.

Design outcomes

Primary

MeasureTime frame
Frequency of primary aldosteronism

Countries

Japan

Contacts

Public ContactToru Setoyama

Japan Physicians Association Secretariat

jpa@oregano.ocn.ne.jp03-3259-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026